JY
QNRX

Jeff Yass’s Quoin Pharmaceuticals QNRX Stock Holding History

Jeff Yass’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-320
Closed -$2.57K – 13527
2025
Q1 		$2.57K Buy
+320
New +$4.21K ﹤0.01% 12295
2024
Q3 		– Sell
-441
Closed -$8.97K – 12831
2024
Q2 		$8.97K Buy
+441
New +$11.2K ﹤0.01% 11785
2024
Q1 		– Sell
-599
Closed -$100K – 13122
2023
Q4 		$100K Buy
+599
New +$92.1K ﹤0.01% 11328
2023
Q3 		– Sell
-95
Closed -$19.7K – 12785
2023
Q2 		$19.7K Buy
+95
New +$19.6K ﹤0.01% 11640
2023
Q1 		– Sell
-52
Closed -$31.1K – 13310
2022
Q4 		$31.1K Buy
52
+15
+41% +$11.3K ﹤0.01% 11609
2022
Q3 		$34K Buy
+37
New +$76.1K ﹤0.01% 12410
2019
Q4 		– Sell
-1
Closed -$44K – 10443
2019
Q3 		$44K Hold
1
– – ﹤0.01% 9811
2019
Q2 		$50K Hold
1
– – ﹤0.01% 9841
2019
Q1 		$78K Buy
+1
New +$179K ﹤0.01% 8343
2018
Q4 		– Hold
0
– – – 8510
2018
Q3 		– Sell
-1
Closed -$602K – 8157
2018
Q2 		$439K Hold
1
– – ﹤0.01% 7054
2018
Q1 		$434K Buy
+1
New +$826K ﹤0.01% 6919
2017
Q4 		– Hold
0
– – – 8739
2017
Q3 		– Hold
0
– – – 8358

Other funds holding QNRX

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jeff Yass's QNRX Position: Q2 2025 in Review

Jeff Yass sold out of Quoin Pharmaceuticals (QNRX) in Q2 2025, closing a stake of 320 shares — an estimated $2.57K sold.

Jeff Yass first reported a position in QNRX in Q1 2018 and held it in 11 quarters. The position peaked at $439K in Q2 2018. 7 funds tracked by Wall St. Rank hold QNRX as of Q2 2025.

  • Jeff Yass reported no remaining Quoin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Jeff Yass sold 320 Quoin Pharmaceuticals shares in Q2 2025, an estimated $2.57K.
  • Jeff Yass first reported a position in Quoin Pharmaceuticals in Q1 2018 and held it in 11 quarters.
  • Jeff Yass's Quoin Pharmaceuticals position peaked at $439K in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.